Atorvastatin and Aβ(1-40): Not as Simple as Cholesterol Reduction in Brain and Relevance to Alzheimer Disease

被引:10
作者
Butterfield, D. Allan [1 ,2 ]
机构
[1] Univ Kentucky, Ctr Membrane Sci, Dept Chem, Lexington, KY 40506 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
关键词
HMG-COA REDUCTASE; NITRIC-OXIDE SYNTHASE; CELLULAR STRESS-RESPONSE; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; A-BETA ACCUMULATION; OXIDATIVE STRESS; AMYLOID-BETA; STATIN THERAPY; LIPID-PEROXIDATION;
D O I
10.1016/j.expneurol.2010.12.014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:15 / 18
页数:4
相关论文
共 86 条
[51]   Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol [J].
Petanceska, SS ;
DeRosa, S ;
Sharma, A ;
Diaz, N ;
Duff, K ;
Tint, SG ;
Refolo, LM ;
Pappolla, M .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 20 (03) :395-406
[52]   Statin therapy for Alzheimer's disease - Will it work? [J].
Petanceska, SS ;
DeRosa, S ;
Olm, V ;
Diaz, N ;
Sharma, A ;
Thomas-Bryant, T ;
Duff, K ;
Pappolla, M ;
Refolo, LM .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (1-2) :155-161
[53]   Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1-40 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage [J].
Piermartiri, Tetsade C. B. ;
Figueiredo, Claudia P. ;
Rial, Daniel ;
Duarte, Filipe S. ;
Bezerra, Sarah C. ;
Mancini, Gianni ;
de Bern, Andreza F. ;
Prediger, Rui D. S. ;
Tasca, Carla I. .
EXPERIMENTAL NEUROLOGY, 2010, 226 (02) :274-284
[54]   The neurobiology of isoprostanes and Alzheimer's disease [J].
Pratico, Domenico .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (08) :930-933
[55]   Statin use and the risk of incident dementia - The cardiovascular health study [J].
Rea, TD ;
Breitner, JC ;
Psaty, BM ;
Fitzpatrick, AL ;
Lopez, OL ;
Newman, AB ;
Hazzard, WR ;
Zandi, PP ;
Burke, GL ;
Lyketsos, CG ;
Bernick, C ;
Kuller, LH .
ARCHIVES OF NEUROLOGY, 2005, 62 (07) :1047-1051
[56]   A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease [J].
Refolo, LM ;
Pappolla, MA ;
LaFrancois, J ;
Malester, B ;
Schmidt, SD ;
Thomas-Bryant, T ;
Tint, GS ;
Wang, R ;
Mercken, M ;
Petanceska, SS ;
Duff, KE .
NEUROBIOLOGY OF DISEASE, 2001, 8 (05) :890-899
[57]   Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model [J].
Refolo, LM ;
Pappolla, MA ;
Malester, B ;
LaFrancois, J ;
Bryant-Thomas, T ;
Wang, R ;
Tint, GS ;
Sambamurti, K ;
Duff, K .
NEUROBIOLOGY OF DISEASE, 2000, 7 (04) :321-331
[58]  
Riekse RG, 2006, J ALZHEIMERS DIS, V10, P399
[59]   Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease [J].
Rockwood, K. .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 :71-77
[60]   Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people [J].
Rockwood, K ;
Kirkland, S ;
Hogan, DB ;
MacKnight, C ;
Merry, H ;
Verreault, R ;
Wolfson, C ;
McDowell, I .
ARCHIVES OF NEUROLOGY, 2002, 59 (02) :223-227